1
|
Guziński M, Krajewski W, Tomczak W, Nowak Ł, Łaszkiewicz J, Chorbińska J, Chełmoński A, Małkiewicz B, Szydełko T. Percutaneous cryoablation of renal tumours under computed tomography guidance: methodology of the procedure. Pol J Radiol 2024; 89:e526-e530. [PMID: 39777325 PMCID: PMC11704947 DOI: 10.5114/pjr/193205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2024] [Accepted: 09/11/2024] [Indexed: 01/11/2025] Open
Abstract
Purpose The incidence of renal cell carcinoma has been steadily increasing over the past two decades, raising the need for minimally invasive approaches. We sought to present the methodology of the percutaneous cryoablation (PCA) procedure developed based on one year of experience with 81 PCA procedures. Material and methods The percutaneous cryoablation programme at Wroclaw Medical University Hospital has been successfully operating for a year. During this period, patients who were ineligible for partial nephrectomy either because of numerous comorbidities or strong preference against surgery were treated with PCA. Each procedure was conducted with the close cooperation of an interventional radiologist and a urologist. Results Over the past year, 81 procedures in 74 individuals have been performed and thoroughly analysed. The mean and median effective radiation doses were 12.57 mSv and 10.76 mSv, respectively. Comprehensive details of our workflow are described within the body of the manuscript. Conclusions Percutaneous cryoablation is a technically effective treatment approach for carefully selected individuals with small renal masses. However, starting a PCA programme from scratch necessitates creation of detailed protocols, as well as close interventional radiologist and urologist cooperation. This review outlines the established workflow and shares insights gained from one year of experience with percutaneous cryoablation.
Collapse
Affiliation(s)
- Maciej Guziński
- Department of General Radiology, Interventional Radiology and Neuroradiology, Wroclaw Medical University, Wroclaw, Poland
| | - Wojciech Krajewski
- Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, Wroclaw, Poland
| | - Wojciech Tomczak
- University Center of Excellence in Urology, Wroclaw Medical University, Wroclaw, Poland
| | - Łukasz Nowak
- Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, Wroclaw, Poland
| | - Jan Łaszkiewicz
- University Center of Excellence in Urology, Wroclaw Medical University, Wroclaw, Poland
| | - Joanna Chorbińska
- Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, Wroclaw, Poland
| | - Adam Chełmoński
- University Center of Excellence in Urology, Wroclaw Medical University, Wroclaw, Poland
| | - Bartosz Małkiewicz
- Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, Wroclaw, Poland
| | - Tomasz Szydełko
- University Center of Excellence in Urology, Wroclaw Medical University, Wroclaw, Poland
| |
Collapse
|
2
|
Radosa CG, Nadjiri J, Mahnken AH, Bücker A, Heuser LJ, Morhard D, Landwehr P, Berlis A, Katoh M, Reimer P, Schachtner B, Ingrisch M, Paprottka P, Hoffmann RT. Availability of Interventional Oncology in Germany in the Years 2018 and 2019 - Results from a Nationwide Database (DeGIR Registry Data). ROFO-FORTSCHR RONTG 2022; 194:755-761. [PMID: 35211926 DOI: 10.1055/a-1729-0951] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
OBJECTIVE Over the past few decades, radiology has established itself in tumor therapy through interventional oncology including innovative and efficient procedures for minimalinvasive treatment of various tumor entities besides the "classic" therapeutic options such as surgery, chemotherapy and radiotherapy.Aim of this study was to evaluate the extent to which interventional oncology can provide nationwide care using the data from the register of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR registry), which records radiological interventions as part of quality assurance. METHODS The numbers of interventions of participating clinics, which were recorded as part of module D (oncological procedures including TACE or other tumor-specific embolization, ablation, percutaneous tumor therapy) and identified by the DeGIR registry between 2018 and 2019, were analyzed retrospectively. The collected intervention data were evaluated regarding federal states and 40 smaller regions (administrative districts and former administrative districts). RESULTS In 2018, 11 653 oncological interventions in 187 clinics were recorded by the DeGIR registry. In 2019, the number of participating clinics rose to 216 and the number of oncological interventions increased by 6 % to 12 323. The average number of oncological interventions per clinic decreased slightly from 62.5 (2018) to 57.1 (2019). The DeGIR requirement for being certified as a training center was met by 116 clinics in 2018 including 31 clinics with more than 100 interventions and 129 clinics in 2019 including 36 with more than 100 interventions. Oncological interventions have been performed in each of the 40 regions. An average of 599 interventions per region (standard deviation of 414) was recorded in the period between 2018 and 2019. CONCLUSION Based on the distribution of the documented oncological interventions at federal state level as well as the district level, the supply of interventional tumor therapy depends on the geographical location. Therefore, the demand of oncological interventions might not be sufficiently covered in some regions. KEY POINTS · Interventional-oncological tumor therapies are performed throughout Germany. · Looking at the notable geographical differences, the need for interventional oncological procedures does not seem to be sufficiently met.. · In order to improve the comprehensive provision of oncological interventions, the training of interventional radiologists should be promoted further.. CITATION FORMAT · Radosa CG, Nadjiri J, Mahnken AH et al. Availability of Interventional Oncology in Germany in the Years 2018 and 2019 - Results from a Nationwide Database (DeGIR Registry Data). Fortschr Röntgenstr 2022; DOI: 10.1055/a-1729-0951.
Collapse
Affiliation(s)
- Christoph Georg Radosa
- Department of Diagnostic and Interventional Radiology, University Hospital Carl Gustav Carus, TU Dresden, Germany
| | - Jonathan Nadjiri
- Department of Interventional Radiology, Klinikum rechts der Isar of the Technical University of Munich, Germany
| | - Andreas H Mahnken
- Diagnostic & Interventional Radiology, Philipps-University Marburg, Germany.,c/o Deutsche Röntgengesellschaft e. V., Board member of the German Society for Interventional Radiology and Microinvasive Therapy (DeGIR), Berlin, Germany
| | - Arno Bücker
- Clinic of Diagnostic and Interventional Radiology, Saarland University Medical Center, Homburg, Germany
| | - Lothar J Heuser
- Diagnostic and Interventional Radiology, Ruhr-Universität Bochum, Germany
| | - Dominik Morhard
- Radiology and Neuroradiology, Leopoldina-Krankenhaus der Stadt Schweinfurt GmbH, Schweinfurt, Germany
| | - Peter Landwehr
- Department for Diagnostic and Interventional Radiology, Diakoniekrankenhaus Henriettenstiftung, Hannover, Germany.,c/o Deutsche Röntgengesellschaft e. V., Board member of the German Society for Interventional Radiology and Microinvasive Therapy (DeGIR), Berlin, Germany
| | - Ansgar Berlis
- Department of Diagnostic and Interventionell Radiology and Neuroradiology, University Hospital Augsburg, Germany.,c/o Deutsche Röntgengesellschaft e. V., Board member of the German Society for Interventional Radiology and Microinvasive Therapy (DeGIR), Berlin, Germany
| | - Marcus Katoh
- Diagnostische und Interventionelle Radiologie, Helios Klinikum Krefeld, Germany.,c/o Deutsche Röntgengesellschaft e. V., Board member of the German Society for Interventional Radiology and Microinvasive Therapy (DeGIR), Berlin, Germany
| | - Peter Reimer
- Zentralinstitut für bildgebende Diagnostik, Städtisches Klinikum Karlsruhe, Germany.,c/o Deutsche Röntgengesellschaft e. V., Board member of the German Society for Interventional Radiology and Microinvasive Therapy (DeGIR), Berlin, Germany
| | - Balthasar Schachtner
- Department of Radiology, Ludwig-Maximilians-Universität München, Munich, Germany.,Member of the German Center for Lung Research (DZL), Comprehensive Pneumology Center (CPC-M), Munich, Germany
| | - Michael Ingrisch
- Department of Radiology, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Philipp Paprottka
- Department of Interventional Radiology, Klinikum rechts der Isar of the Technical University of Munich, Germany.,c/o Deutsche Röntgengesellschaft e. V., Board member of the German Society for Interventional Radiology and Microinvasive Therapy (DeGIR), Berlin, Germany
| | - Ralf-Thorsten Hoffmann
- Department of Diagnostic and Interventional Radiology, University Hospital Carl Gustav Carus, TU Dresden, Germany.,c/o Deutsche Röntgengesellschaft e. V., Board member of the German Society for Interventional Radiology and Microinvasive Therapy (DeGIR), Berlin, Germany
| |
Collapse
|